Immunophenotypic and molecular studies
| Patient no. . | cCD3 . | CD56 . | TIA/GRZB . | CD7 . | CD5 . | CD4/CD8 . | CD20 . | CD43 . | EBER . | TCR . |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | + | + | + | + | − | − | − | + | − | Polyclonal |
| 2 | + | + | NA | + | − | − | − | + | − | Polyclonal |
| 3 | + | + | + | + | − | − | − | + | − | Polyclonal |
| 4 | + | + | + | + | − | − | − | + | − | Polyclonal |
| 5 | + | + | + | + | − | − | − | NA | − | Polyclonal |
| 6 | + | + | + | + | − | − | − | + | − | Polyclonal |
| 7 | + | + | + | + | − | − | − | + | − | Oligoclonal |
| 8 | + | + | + | NA | − | − | − | + | − | Polyclonal |
| Patient no. . | cCD3 . | CD56 . | TIA/GRZB . | CD7 . | CD5 . | CD4/CD8 . | CD20 . | CD43 . | EBER . | TCR . |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | + | + | + | + | − | − | − | + | − | Polyclonal |
| 2 | + | + | NA | + | − | − | − | + | − | Polyclonal |
| 3 | + | + | + | + | − | − | − | + | − | Polyclonal |
| 4 | + | + | + | + | − | − | − | + | − | Polyclonal |
| 5 | + | + | + | + | − | − | − | NA | − | Polyclonal |
| 6 | + | + | + | + | − | − | − | + | − | Polyclonal |
| 7 | + | + | + | + | − | − | − | + | − | Oligoclonal |
| 8 | + | + | + | NA | − | − | − | + | − | Polyclonal |
cCD3 indicates cytoplasmic CD3; GRZB, Granzyme B; EBER, Epstein-Barr virus-encoded RNA; TCR, T-cell receptor-γ gene rearrangement by polymerase chain reaction; +, positive; −, negative; and NA, not applicable.